The Traderszone Network

18 July, 2014 by The TZ Newswire Staff Comments Off on Why Nu Skin Enterprises and B&G Foods Dropped Today

Why Nu Skin Enterprises and B&G Foods Dropped Today

The blue chips bounced back today on strong earnings from Google and other major companies, but Nu Skin Enterprises and B&G Foods still finished lower.

read more

18 July, 2014 by The TZ Newswire Staff Comments Off on Goldman Slams Abenomics; Questions "Validity Of BoJ’s Target"

Goldman Slams Abenomics; Questions "Validity Of BoJ’s Target"

While we have again and again explained why Abenomics is ultimately doomed as you simply cannot print your way to prosperity (a message The Fed appears to be discovering rapidly), when Goldman Sachs unleashes an Abenomics-bashing piece, one has to wonder just what options Abe has left as economic data starts to collapse (and approval ratings drop just as fast).

Via Goldman Sachs,

Corporate pricing bearish again on falling demand after post-tax hike

 

read more

18 July, 2014 by The TZ Newswire Staff Comments Off on The Surprising Market Where Apple, Inc. Is Missing a Big Opportunity

The Surprising Market Where Apple, Inc. Is Missing a Big Opportunity

A new Apple TV feature could prove meaningful for Hollywood.

read more

18 July, 2014 by The TZ Newswire Staff Comments Off on Understanding Android’s Growing Importance to Google, Inc. Stock

Understanding Android’s Growing Importance to Google, Inc. Stock

A plan to offer free training to developers reveals how important the OS is to the future of the business, and to Google, Inc. stock.

read more

18 July, 2014 by The TZ Newswire Staff Comments Off on U.S. drugmaker AbbVie finally wins Dublin’s Shire with $55 billion deal

U.S. drugmaker AbbVie finally wins Dublin’s Shire with $55 billion deal

U.S. drugmaker AbbVie Inc bought Dublin-based Shire Plc on Friday in a 32 billion pound ($54.7 billion) deal that will allow it to slash its tax bill by relocating to Britain. The London-listed company, which makes expensive medicines to treat rare diseases, fought off four earlier bids from AbbVie until the U.S. firm raised its price to 52.48 pounds per share – made up of 24.44 pounds in cash and 0.8960 new AbbVie shares. Chicago-based AbbVie is buying Shire to cut both its U.S. tax bill and its reliance on arthritis drug Humira, the world’s top selling medicine which loses U.S.

read more

18 July, 2014 by The TZ Newswire Staff Comments Off on World GDP Hopes Are Collapsing

World GDP Hopes Are Collapsing

Presented with no comment (except to note how different the “fact” in this chart is from the “fantasy” we hear spewed day after day about ‘recovery’ in the world’s economy)

 

 

Chart: Bloomberg

read more

18 July, 2014 by The TZ Newswire Staff Comments Off on How the Dow’s Pharma Stocks Helped Boost Markets Friday

How the Dow’s Pharma Stocks Helped Boost Markets Friday

Merck and Johnson & Johnson both pushed higher, helping the Dow recover from Thursday’s weakness.

read more